Answers are grounded in this paper and cite their sources.
( Anesthesiology . 2026;144(2):390–401. doi: 10.1097/ALN.0000000000005794) Administering drugs into the cerebrospinal fluid (CSF) via the spinal route bypasses the blood-brain barrier that lowers the central nervous system (CNS) availability of many systemically administered drugs. Intracranial therapeutic drug (gene therapy, antinociceptive drugs, antimicrobials, spasticity drugs, and chemotherapy) administration can have many risks, while evidence supports that lumbar intrathecal drug administration fails to deliver therapeutic concentrations to the brain. CSF moving along the glymphatic pathway can be altered with many drugs, such as anesthetics and hypertonic saline (HTS). Significant future interest in lumbar administration of medications for intracranial effects exists. This article analyzes how 2 anesthetic regimens and HTS affect a high-molecular-weight radiotracer that is delivered intrathecally.
No takes yet. Share an insight, caveat, or question.
Persson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: